A new gas chromatography-mass spectrometry method for simultaneous determination of total and free trans-3'-hydroxycotinine and cotinine in the urine of subjects receiving transdermal nicotine

Clinical Chemistry

Volumn 45, Issue 1, 1999, Pages 85-91

  Ji, Allena J ^a,c   Lawson, George M ^a   Anderson, Rodger ^a   Dale, Lowell C ^b   Croghan, Ivana T ^b   Hurt, Richard D ^b  

^a Department of Lab Med and Pathol ^*  (United States)

^b MAYO CLINIC   (United States)

^c Kansas City Analytical Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; COTININE; NICOTINE;

ADULT; ARTICLE; DRUG DETERMINATION; DRUG METABOLISM; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; QUANTITATIVE ASSAY; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION; URINARY EXCRETION;

EID: 0032953670     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.1.85     Document Type: Article

References (24)

1. 1. McKennis H, Turnball LB, Bowman ER, Wada E. Demethylation of cotinine in man. J Am Chem Soc 1959;81:3951-4.
2. 2. McKennis H, Turnball LB, Schwarte SL, Tamaki E, Bowman ER. Demethylation in the metabolism of (-)-nicotine. J Biol Chem 1962;237:541-6.
3. 3. Bowman ER, McKennis H. Studies on the metabolism of (-)-cotinine in the human. J Pharmacol Exp Ther 1962;135:306-11.
4. 4. Dagne E, Castagndi N. Cotinine N-oxide, a new metabolite of nicotine. J Med Chem 1972;15:840-1.
5. 5. Neurath GB, Pein FG. Gas Chromatographic determination of trans-3'-hydroxycotinine, a major metabolite of nicotine in smokers. J Chromatogr 1987;415:400-6.
6. 6. Neurath GB, Dunger M, Orth D, Pein FG. trans-3'-hydroxycotinine as a main metabolites in urine of smokers. Int Arch Occup Environ Health 1987;59:199-201.
7. 7. Jacob P III, Benowitz NL, Shulgin AT. Recent studies of nicotine metabolism in human. Pharmacol Biochem Behav 1988;30:249-53.
8. 8. Schere G, Jarczyk L, Heller WD, Biber A, Neurath GB, Adlkofer A. Pharmacokinetics of nicotine, cotinine, and 3'-hydroxycotinine in cigarette smokers. Klin Wochenschr 1988;66:5-11.
9. 9. McManus KT, Debethizy KM, Garteiz DA, Kyerematen GA, Vesell ES. A new quantitative thermospray LC-MS method for nicotine and its metabolites in biological fluids. J Chromatogr Sci 1990; 28:510-6.
10. 10. Pichini S, Altieri I, Pacifici R, Rosa M. Simultaneous determination of cotinine and trans-3'-hydroxycotinine in human serum by high-performance liquid chromatography. J Chromatogr 1992;577: 358-61.
11. 11. Rop PP, Grimaldi F, Oddoze C, Viala A. Determination of nicotine and its metabolites in urine by high-performance liquid chromatography. J Chromatogr 1993;612:302-9.
12. 12. Moore J, Greenwood M, Sinclair N. Automation of a high performance liquid Chromatographic assay for the determination of nicotine, cotinine and 3-hydroxycotinine in human urine. J Pharm Biomed Anal 1990;8:1051-4.
13. 13. Pacific R, Pichini S, Altieri I, Rosa M, Bacosi A, Caronna A, Zuccaro P. Determination of nicotine and two major metabolites in serum by solid-phase extraction and high-performance liquid chromatography-particle beam mass spectrometry. J Chromatogr 1993;612: 209-13.
14. 14. Jacob P III, Shulgin AT, Yu L, Benowitz ML. Determination of the nicotine metabolite trans-3'-hydroxycotinine in urine of smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring. J Chromatogr 1992;583:145-54.
15. 15. Voncken P, Schepers G, Schafer KH. Capillary gas Chromatographic determination of trans-3'-hydroxycotinine simultaneously with nicotine and cotinine in urine and blood samples. J Chromatogr 1989;479:410-8.
16. 16. Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, et al. Application of urine nicotine and cotinine excretion rates to assess nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 1998; 38:510-6.
17. 17. Baskin LB, Anderson RW, Charlson JR, Hurt RD, Lawson GM. Determination of nicotine in serum and urine by isotope dilution using solid-phase extraction and gas chromatography/mass spectrometry with selected ion monitoring. Ann Clin Biochem 1998; 35:522-7.
18. 18. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy, percentage of replacement and smoking cessation. JAMA 1995;274:1353-8.
19. 19. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetics studies. J Pharm Sci 1992;81:309-12.
20. 20. Byrd GD, Chang KM, Green JM, deBethizy JD. Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers. Drug Metab Dispos 1992; 20:192-7.
21. 21. Machacek DA, Jiang NS. Quantitation of cotinine in plasma and saliva by liquid chromatography. Clin Chem 1986;32:979-82.
22. 22. Benowitz NL, Jacob P III, Fong I, Gupta S. Nicotine metabolic profile in main: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994;268:296-303.
23. 23. Kyerematen GA, Vesell ES. Metabolism of nicotine. Drug Metab Rev 1991;23:3-41.
24. 24. Bannon YB, Corish J, Corrigan OI, Devane JG, Kavanagh M, Mulligan S. Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study. Eur J Clin Pharmacol 1989;37:285-90.